Tekla Healthcare Investors
NYSE:HQH
15.2 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 10.769 | 10.292 | 8.271 | 6.48 | 8.933 | 7.601 | 6.784 | 5.619 | 4.801 | 4.332 | 2.144 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 10.769 | 10.292 | 8.271 | 6.48 | 8.933 | 7.601 | 6.784 | 5.619 | 4.801 | 4.332 | 2.144 |
| Gross Profit Ratio
| 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 10.933 | 11.477 | 11.941 | 12.711 | 10.905 | 10.473 | 10.905 | 10.783 | 11.084 | 12.182 | 9.301 |
| Selling & Marketing Expenses
| 0.056 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 10.99 | 11.477 | 11.941 | 12.711 | 10.905 | 10.473 | 10.905 | 10.783 | 11.084 | 12.182 | 9.301 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 10.99 | 11.477 | 11.941 | 12.711 | 10.905 | 10.473 | 10.905 | 10.783 | 11.084 | 12.182 | 9.301 |
| Operating Income
| -0.22 | -1.185 | -3.67 | -6.23 | -1.972 | -2.872 | -4.121 | -5.164 | -6.283 | -7.851 | -7.157 |
| Operating Income Ratio
| -0.02 | -0.115 | -0.444 | -0.961 | -0.221 | -0.378 | -0.607 | -0.919 | -1.309 | -1.812 | -3.338 |
| Total Other Income Expenses Net
| 185.167 | 57.52 | -190.559 | 161.406 | 243.176 | -142.423 | 73.324 | 126.447 | -49.736 | 104.016 | 229.174 |
| Income Before Tax
| 184.947 | 56.335 | -194.229 | 155.176 | 241.205 | -145.295 | 69.204 | 121.283 | -56.019 | 96.165 | 222.017 |
| Income Before Tax Ratio
| 17.174 | 5.474 | -23.484 | 23.946 | 27.001 | -19.115 | 10.201 | 21.584 | -11.667 | 22.201 | 103.55 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| 184.947 | 56.335 | -194.229 | 155.176 | 241.205 | -145.295 | 69.204 | 121.283 | -56.019 | 96.165 | 222.017 |
| Net Income Ratio
| 17.174 | 5.474 | -23.484 | 23.946 | 27.001 | -19.115 | 10.201 | 21.584 | -11.667 | 22.201 | 103.55 |
| EPS
| 3.55 | 1.14 | -4.1 | 3.42 | 5.5 | -3.39 | 1.64 | 2.98 | -1.44 | 2.58 | 6.2 |
| EPS Diluted
| 3.55 | 1.14 | -4.1 | 3.42 | 5.5 | -3.39 | 1.64 | 2.98 | -1.44 | 2.58 | 6.2 |
| EBITDA
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |